Literature DB >> 3723559

Is reserpine a human teratogen?

R M Pauli, B J Pettersen.   

Abstract

A single stillborn female with craniofacial, abdominal, and central nervous system malformations was exposed to reserpine during the first six weeks of gestation. Parallels between the malformations present in this infant and those induced in rats through exposure to reserpine at analogous periods of gestation suggest that reserpine may pose specific risks for malformations in some pregnancies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723559      PMCID: PMC1049642          DOI: 10.1136/jmg.23.3.267

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  3 in total

1.  TERATOGENIC ACTION IN RATS OF RESERPINE ALONE AND IN COMBINATION WITH SALICYLATE AND IMMOBILIZATION.

Authors:  A S GOLDMAN; W C YAKOVAC
Journal:  Proc Soc Exp Biol Med       Date:  1965-04

2.  Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine.

Authors:  D E SOBEL
Journal:  AMA Arch Gen Psychiatry       Date:  1960-06

3.  Spectrum of anomalies in the Meckel syndrome, or: "Maybe there is a malformation syndrome with at least one constant anomaly".

Authors:  F C Fraser; A Lytwyn
Journal:  Am J Med Genet       Date:  1981
  3 in total
  1 in total

1.  Accuracy of fetal death reports: comparison with data from an independent stillbirth assessment program.

Authors:  A E Greb; R M Pauli; R S Kirby
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.